최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기식품과학과 산업 = Food science and industry, v.51 no.4, 2018년, pp.302 - 312
김선영 (국민대학교 식품영양학과) , 임지영 (국민대학교 식품영양학과)
Bioactive peptides generated from milk proteins play an important role in the prevention and alleviation of diabetes. Whey proteins possess direct insulinotropic effect by amino acids (especially branch chain amino acids) produced through its gastrointestinal digestion. Additionally, blood glucose l...
* AI 자동 식별 결과로 적합하지 않은 문장이 있을 수 있으니, 이용에 유의하시기 바랍니다.
핵심어 | 질문 | 논문에서 추출한 답변 |
---|---|---|
단백질이 신체에서 수행하는 역할은 무엇인가? | 생체 내에서 단백질은 뇌하수체, 내분비계, 및 신경계 말단에서 펩타이드 호르몬의 형태로 분비되어 체내 항상성 유지를 위한 대사과정(신경전달, 혈압조절, 혈당조절 등)을 조절함은 물론 신경전달물질 또는 면역조절물질로서 인지기능과 생체방어기능에도 기여한다(Hruby와 Balse, 2000). 우리가 섭취하는 식품에 존재하는 단백질은 영양소를 제공하는 에너지원의 기능뿐만 아니라 소화과정에서 다양한 펩타이드를 형성하여 생체 조절 효과를 나타낸다. | |
단백질은 무엇인가? | 단백질은 아미노산들이 펩타이드 결합으로 연결된 중합체로, 생리적 효과를 발휘하기 위해서는 일차적으로 장관상피세포를 통하여 흡수되어 혈액을 통하여 표적기관에 도달하여야 한다. 장관 상피세포에서 기능성 펩타이드의 흡수는 Fig. | |
우유단백질 섭취 시, 신체에 어떤 영향을 주는가? | 단백질 함량을 보정하여 준비 된 네 가지 시료, 참치, 칠면조, 유청, 난백 식단 중 특히 유청은 인슐린 분비 촉진 효과가 가장 높았으며, 혈당 저하 효과도 다른 단백질 식단과 비교하여 유의적으로 우수하였다(Pal 과 Ellis, 2010). 유청단백질의 식후 혈당 감소 효과는 여러 연구자에 의하여 재확인되었으며, 유청단백질 혹은 유청단백질 가수분해물(20 g/1회 분량)의 공급은 건강한 성인에서 고탄수화물 섭취 전후에 모두 농도의존적으로 인슐린 분비를 증가시키고, 혈당을 감소시켰다(Petersen 등, 2009; Akhavan 등, 2010). 유청단백질의 인슐린 분비 촉진 및 혈당 감소 효과는 건강한 성인의 경우 이외에도 2형 당뇨환자의 경우에도 동일한 효과가 관찰되었다(Frid 등, 2005). |
Adessi C, Soto C. Converting a peptide into a drug: Strategies to improve stability and bioavailability. Curr. Med. Chem. 9: 963-978 (2002)
Akhavan T, Luhovyy BL, Brown PH, Cho CE, Anderson GH. Effect of premeal consumption of whey protein and its hydrolysate on food intake and postmeal glycemia and insulin responses in young adults. Am. J. Clin. Nutr. 91: 966-975 (2010)
Appuhamy JA, Knoebel NA, Nayananjalie WA, Escobar J, Hanigan MD. Isoleucine and leucine independently regulate mTOR signaling and protein synthesis in MAC-T cells and bovine mammary tissue slices. J. Nutr. 142: 484-491 (2012)
Boirie Y, Dangin M, Gachon P, Vasson MP, Maubois JL, Beaufrere B. Slow and fast dietary proteins differently modulate postprandial protein accretion. Proc. Natl. Acad. Sci. USA 94: 14930-14935 (1997)
Brubaker PL, Drucker DJ. Minireview: glucagon-like peptides regulate cell proliferation and apoptosis in the pancreas, gut, and central nervous system. Endocrinology 145: 2653-2659 (2004)
Calbet JA, Holst JJ. Gastric emptying, gastric secretion and enterogastrone response after administration of milk proteins or their peptide hydrolysates in humans. Eur. J. Nutr. 43: 127-139 (2004)
Cho YM, Fujita Y, Kieffer TJ. Glucagon-like peptide-1: glucose homeostasis and beyond. Annu. Rev. Physiol. 76: 535-559 (2014)
Daniel H. Molecular and integrative physiology of intestinal peptide transport. Annu. Rev. Physiol. 66: 361-384 (2004)
DeFronzo RA, Ferrannini E. Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 14: 173-194 (1991)
Drucker DJ, Nauck MA. The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes. Lancet 368:1696-1705 (2006)
Dullius A, Goettert MI, de Souza CFV. Whey protein hydrolysates as a source of bioactive peptides for functional foods-Biotechnological facilitation of industrial scale-up. J. Func. Foods 42: 58-74 (2018)
Fernandez A, Riera F. ${\beta}$ -Lactoglobulin tryptic digestion: A model approach for peptide release. Biochem. Eng. J. 70: 88-96 (2013)
FitzGerald RJ, Meisel H. Milk protein-derived peptide inhibitors of angiotensin-I-converting enzyme. Br. J. Nutr. 84: 33-37 (2000)
Frid AH, Nilsson M, Holst JJ, Bjorck IM. Effect of whey on blood glucose and insulin responses to composite breakfast and lunch meals in type 2 diabetic subjects. Am. J. Clin. Nutr. 82: 69-75 (2005)
Gilbert ER, Wong EA, Webb Jr. KE. Peptide absorption and utilization: Implications for animal nutrition and health. J. Anim. Sci. 86: 2135-2155 (2008)
Gooben K, Graber S. Longer term safety of dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes mellitus: systematic review and meta-analysis. Diabetes Obes. Metab. 14: 1061-1072 (2012)
Guo HY, Pang K, Zhang XY, Zhao L, Chen SW, Dong ML, Ren FZ. Composition, physicochemical properties, nitrogen fraction distribution, and amino acid profile of donkey milk. J Dairy Sci. 90: 1635-1643 (2007)
Halton TL, Hu FB. The effects of high protein diets on thermogenesis, satiety and weight loss: a critical review. J. Am. Coll. Nutr. 23: 373-85 (2004)
Hruby VJ, Balse PM. Conformational and topographical considerations in designing agonist peptidomimetics from peptide leads. Curr. Med. Chem. 7: 945-970 (2000)
Hunziker D, Hennig M, Peters JU. Inhibitors of dipeptidyl peptidase IV - recent advances and structural views. Curr. Topics Med. Chem. 5: 1623-1637 (2005)
Lacroix IME, Li-Chan ECY. Dipeptidyl peptidase-IV inhibitory activity of dairy protein hydrolysates. Int. Dairy J. 25: 97-102 (2012)
Lara-Villoslada F, Olivares M, Xaus J. The balance between caseins and whey proteins in cow's milk determines its allergenicity. J. Dairy Sci. 88: 1654-1660 (2005)
Layman DK, Evans EM, Erickson D, Seyler J, Weber J, Bagshaw D, Griel A, Psota T, Kris-Etherton P. A moderate protein diet produces sustained weight loss and long-term changes in body composition and blood lipids in obese adults. J. Nutr. 139: 514-521 (2009)
Layman DK, Walker DA. Potential importance of leucine in treatment of obesity and the metabolic syndrome. J. Nutr. 136: 319S-23S (2006)
Marya, Khan H, Nabavi SM, Habtemariam S. Anti-diabetic potential of peptides: future prospects as therapeutic agents. Life Sci. 193: 153-158 (2018)
Mennella C, Visciano M, Napolitano A, Del Castillo MD, Fogliano V. Glycation of lysine-containing dipeptides. J. Pept. Sci.12: 291-296 (2006)
Mentlein R. Therapeutic assessment of glucagons-like peptide-1 agonists compared with dipeptidyl peptidase IV inhibitors as potential antidiabetic drugs. Expert Opin. Invest. Drugs 14: 57-64 (2005)
Nielsen, SD, Beverly, RL, Qu Y, Dallas DC. Milk bioactive peptide database: A comprehensive database of milk protein-derived bioactive peptides and novel visualization. Food Chem. 232: 673-682 (2017)
Nilsson M, Holst JJ, Bjorck IM. Metabolic effects of amino acid mixtures and whey protein in healthy subjects: studies using glucose-equivalent drinks. Am. J. Clin. Nutr. 85: 996-1004 (2007)
Nilsson M, Stenberg M, Frid AH, Holst JJ, Bjorck IM: Glycemia and insulinemia in healthy subjects after lactose-equivalent meals of milk and other food proteins: the role of plasma amino acids and incretins. Am. J. Clin. Nutr. 80: 1246-1253 (2004)
Nongonierma AB, FitzGerald RJ. The scientific evidence for the role of milk protein-derived bioactive peptides in humans: A review. J. Func. Foods 17: 640-656 (2015)
Nongonierma AB, FitzGerald RJ. An in silico model to predict the potential of dietary proteins as sources of dipeptidyl peptidase IV (DPP-IV) inhibitory peptides. Food Chem. 165: 489-498 (2014a)
Nongonierma AB, FitzGerald RJ. Susceptibility of milk protein-derived peptides to dipeptidyl peptidase IV (DPP-IV) hydrolysis. Food Chem. 145: 845-852 (2014b)
Nongonierma AB, FitzGerald RJ. Dipeptidyl peptidase IV inhibitory properties of a whey protein hydrolysate: Influence of fractionation, stability to simulated gastrointestinal digestion and food-drug interaction. Int. Dairy J. 32: 33-39 (2013b)
Ohnuma K, Takahashi N, Yamochi T, Hosono O, Dang NH, Morimoto C. Role of CD26/dipeptidyl peptidase IV in human T cell activation and function. Front Biosci. 13: 2299-2310 (2008)
Pal S, Ellis V. The acute effects of four protein meals on insulin, glucose, appetite and energy intake in lean men. Br. J. Nutr. 104: 1241-1248 (2010)
Petersen BL, Ward LS, Bastian ED, Jenkins AL, Campbell J, Vuksan V. A whey protein supplement decreases post-prandial glycemia. Nutr. J. 8: 47 (2009)
Portha B, Tourrel-Cuzin C, Movassat J. Activation of the GLP-1 receptor signaling pathway: a relevant strategy to repair a deficient beta-cell mass. Exp. Diabetes Res. Article ID 376509 doi:10.1155/2011/376509 (2011)
Pripp AH, Ardo Y. Modelling relationship between angiotensin-(I)-converting enzyme inhibition and the bitter taste of peptides. Food Chem. 102: 880-888 (2007)
Russell-Jones D, Gough S. Recent advances in incretin-based therapies. Clin. Endocrinol. 77: 489-499 (2012)
Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res. Clin. Pract. 87: 4-14 (2010)
Thoma R, Loffler B, Stihle M, Huber W, Ruf A, Hennig M. Structure basis of proline-specific exopeptidase activity as observed in human dipeptidyl peptidase-IV. Structure, 11: 947-959 (2003)
Toft-Nielsen MB, Damholt MB, Madsbad S, Hilsted LM, Hughes TE, Michelsen BK, Holst JJ. Determinants of the impaired secretion of glucagon-like peptide-1 in Type 2 diabetic patients. J. Clin. Endocrinol. Metab. 86: 3717-3723 (2001)
Udenigwe CC, Fogliano V. Food matrix interaction and bioavailability of bioactive peptides: Two faces of the same coin? J. Func. Foods 35: 9-12 (2017)
Wada Y, Lonnerdal B. Effects of different industrial heating processes of milk on site-specific protein modifications and their relation to in vitro and in vivo digestibility. J. Agric. Food Chem. 62: 4175-4185 (2014).
Walzem RL, Dillard CJ, German JB. Whey components: Millennia of evolution create functionalities for mammalian nutrition: What we know and what we may be overlooking. Crit. Rev. Food Sci. Nutr. 42: 353-375 (2002)
Wang JH, Liu YL, Ning JH, Yu NJ, Li XH, Wang FX. Is the structural diversity of tripeptides sufficient for developing functional food additives with satisfactory multiple bioactivities? J. Mol. Struc. 1040: 164-170 (2013)
Yang J, Chi Y, Burkhardt BR, Guan Y, Wolf BA. Leucine metabolism in regulation of insulin secretion from pancreatic beta cells. Nutr Rev. 68: 270-279 (2010)
Zeng Z, Luo J, Zuo F, Zhang Y, Ma H, Chen S. Screening for potential novel probiotic Lactobacillus strains based on high dipeptidyl peptidase IV and ${\alpha}$ -glucosidase inhibitory activity. J. Func. Food 20: 486-495 (2016)
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
출판사/학술단체 등이 한시적으로 특별한 프로모션 또는 일정기간 경과 후 접근을 허용하여, 출판사/학술단체 등의 사이트에서 이용 가능한 논문
※ AI-Helper는 부적절한 답변을 할 수 있습니다.